Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

South Texas Accelerated Research Therapeutics | Researchclopedia

Back to institutions

South Texas Accelerated Research Therapeutics

San Antonio, Texasfacility

1,451

Works

101,576

Citations

140

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research

Top Researchers

Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

5,467 works263,924 citationsh-index: 230

Recent Research

89O BMS-986504 with or without gemcitabine (GEM) + nab-paclitaxel (nab-P) in patients (pts) with pancreatic ductal adenocarcinoma (PDAC) and homozygous MTAP deletion (MTAP-del) from CA240-0007

B. George,Konstantinos Leventakos,et al.

20260 citations

CAR-T cell therapy research

Monoclonal and Polyclonal Antibodies Research

Advanced Breast Cancer Therapies

Colorectal Cancer Treatments and Studies

Cancer Genomics and Diagnostics

Cancer Research and Treatments

Immunotherapy and Immune Responses

Pancreatic and Hepatic Oncology Research

Radiopharmaceutical Chemistry and Applications

Seeram Ramakrishna National University of Singapore

2,351 works177,968 citationsh-index: 197

Jörge E. Cortes Augusta University Health

3,571 works143,300 citationsh-index: 179

Johann S. de Bono Royal Marsden NHS Foundation Trust

2,486 works134,604 citationsh-index: 160

Josep Tabernero Hebron University

2,703 works126,607 citationsh-index: 146

José Baselga Hebron University

1,379 works117,682 citationsh-index: 143

Zanidatamab, a Dual HER2-Targeted Bispecific Antibody, in Patients With Unresectable Locally Advanced or Metastatic HER2-Positive Salivary Gland Cancer: A Combined Analysis of Early-Phase Studies

Keun-Wook Lee,Elena Elimova,et al.

20260 citations

144TiP A first-in-human, open-label, multi-part, phase I/II study of BAY 3713372, a novel 2nd generation PRMT5 inhibitor, in participants with MTAP-deleted solid tumors

David Tai,J. Henry,et al.

20260 citations

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study

Yonina R. Murciano-Goroff,Antoine Hollebecque,et al.

20260 citations

A randomized phase II trial of gemcitabine, nab‐paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer

Gayle Jameson,Denise J. Roe,et al.

20260 citations

BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial

Michael S. Gordon,Richard D. Carvajal,et al.

20260 citations